Capsida Biotherapeutics
Newbury Park
About Capsida Biotherapeutics
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $140.0M
- Last round: Corporate Round (Feb 2023)
- Website: capsida.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/capsida-biotherapeutics-104277 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.